Debt to Equity Ratio Chart

View Debt to Equity Ratio for VALN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2009. Start Trial.
Date Value
March 31, 2026 2.732
December 31, 2025 1.952
September 30, 2025 1.302
June 30, 2025 1.056
March 31, 2025 1.205
December 31, 2024 1.193
September 30, 2024 0.9254
June 30, 2024 1.261
March 31, 2024 1.119
December 31, 2023 1.628
September 30, 2023 1.235
June 30, 2023 0.7825
March 31, 2023 0.7458
December 31, 2022 0.6933
September 30, 2022 0.9796
June 30, 2022 1.432
March 31, 2022 0.7784
December 31, 2021 0.6721
September 30, 2021
June 30, 2021 1.447
March 31, 2021 2.025
December 31, 2020 1.362
September 30, 2020 1.450
June 30, 2020 1.017
March 31, 2020 0.7456
Date Value
December 31, 2019 0.6305
September 30, 2019 0.6368
June 30, 2019 0.6734
March 31, 2019 0.5496
December 31, 2018 0.4023
September 30, 2018 0.6726
June 30, 2018 0.6742
March 31, 2018 0.7022
December 31, 2017 0.7715
September 30, 2017 0.7266
June 30, 2017 0.7548
March 31, 2017 0.7575
December 31, 2016 0.8246
September 30, 2016 0.8219
June 30, 2016 0.7717
March 31, 2016 0.5897
December 31, 2015 0.7085
September 30, 2015 0.606
June 30, 2015 0.5912
March 31, 2015 0.5734
December 31, 2014 0.5878
September 30, 2014 0.5226
June 30, 2014 0.501
March 31, 2014 0.5198
September 30, 2013 0.3418

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Pfizer Inc. 0.7154
Nicox SA --
DBV Technologies SA 0.0784
Cellectis SA 1.812
Inventiva SA --